Telix Pharmaceuticals Limited ADR (TLX) Stock Price, Quote & News

Company Profile

Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250...

Industry: Biotechnology

Sector: Healthcare

Phone: 61 3 9093 3855

Website: telixpharma.com

Address:

55 Flemington Road, Level 4, North Melbourne, Australia

AlertsAndNews Mar. 15 at 9:55 PM

$TLX Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate NDA back in the FDA hands here. "today announces the resubmission of a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX101-Px, (Pixclara®1, Floretyrosine F 18 or 18F-FET), an investigational PET2 imaging agent for the characterization of recurrent or progressive glioma (brain cancer) from treatment related changes in both adult and pediatric patients."

0 · Reply

StockNews_Live Mar. 15 at 9:28 PM

$TLX 🎯 STOCK NEWS ALERT 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Telix Pharmaceuticals Limited announces the resubmission of a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for TLX101-Px, an investigational PET imaging… 📎 https://stocknews.live/news/TLX/telix-resubmits-nda-to-u-s-fda-for-tlx101-px-pixclara-brain-cancer-jgh21wv6fz20

0 · Reply

GreenTeaKor Mar. 10 at 5:48 AM

$TLX hello?

0 · Reply

StockNews_Live Mar. 9 at 11:20 PM

$TLX 🎯 STOCK NEWS ALERT 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Telix Pharmaceuticals Limited announced that Part 1 of the ProstACT Global Phase 3 study has achieved its primary objectives, demonstrating an acceptable safety and tolerability profile with no new… 📎 https://stocknews.live/news/TLX/prost-act-global-phase-88199.html

0 · Reply

StockNews_Live Feb. 27 at 12:02 PM

$TLX Telix Pharmaceuticals Limited announces a research collaboration with University Hospital Essen on the PROMISE-PET registry, defining the potential prognostic value of PSMA-PET imaging through artific…

0 · Reply

prismmarketview Feb. 25 at 7:12 PM

TelixPharma We’ve added Telix Pharmaceuticals Limited (NASDAQ: $TLX) to the PRISM Pharmaceuticals Index. With over $800M in 2025 revenue and multiple late-stage oncology programs advancing, Telix represents a rare disease and precision radiopharmaceutical story with significant clinical and regulatory catalysts ahead. Buy-rated with a $20 price target, TLX remains a name to watch in 2026 as key Phase 3 data and regulatory milestones unfold. https://prismmarketview.com/companies/telix-pharmaceuticals-limited/

0 · Reply

erevnon Feb. 24 at 7:28 PM

Citigroup maintains Telix Pharmaceuticals $TLX at Buy and raises the price target from $22 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

DailyAnalysis Feb. 24 at 6:28 PM

Post-earnings strength has $TLX clearing key 1D moving averages. 1W RSI is finally curling up from oversold levels, while 4H and 30M CCI remain bullish as STOCH enters the upper quintile during this recovery. @DailyAnalysis

0 · Reply

DailyAnalysis Feb. 23 at 3:36 PM

0 · Reply

BillionerOfKing Feb. 23 at 2:30 PM

$TLX Current Stock Price: $6.88

0 · Reply

Telix Resubmits NDA For Brain Cancer Imaging Candidate TLX101-Px To FDA

2026-03-16T00:59:50.000Z - 22 hours ago

Telix Resubmits TLX101-Px NDA To FDA For Brain Cancer Imaging Agent

Sun, 15 Mar 2026 17:25:00 -0400 - 1 day ago

Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate

2026-03-10T11:01:49.000Z - 6 days ago

Why Is Telix Pharmaceuticals Stock Gaining Tuesday?

Mar 10, 2026, 12:47 AM EDT - 6 days ago

Telix Pharmaceuticals Limited (TLX) Discusses ProstACT Global Phase 3 Study Part 1 Results and Safety Profile Transcript

TLX

Mar 9, 2026, 7:19 PM EDT - 7 days ago

ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives

TLX

Mar 5, 2026, 12:42 AM EST - 11 days ago

Telix Pharmaceuticals Limited (TLX) Discusses Physician Perspectives on Innovations in PSMA PET CT Imaging for Prostate Cancer Transcript

TLX

2026-03-03T00:00:12.000Z - 13 days ago

Telix Pharmaceuticals Ltd at TD Cowen Healthcare Conference Transcript

Mar 1, 2026, 10:00 PM EST - 14 days ago

Telix Pharmaceuticals: Scope Of Company Beyond Radio Antibody-Drug Conjugate TLX591-Tx

TLX

Feb 27, 2026, 7:00 AM EST - 17 days ago

Telix Joins Forces with University Hospital Essen on PROMISE-PET: Optimizing Patient Management through AI-enabled PSMA-PET Imaging

TLX

Thu, 26 Feb 2026 05:15:00 -0500 - 18 days ago

1 Basically Unknown Stock That Could Turn Cancer‑Imaging Breakthroughs Into Generational Wealth

2026-02-24T18:31:54.000Z - 20 days ago

Citigroup Raises Price Target on Telix Pharmaceuticals (TLX) to $22.50 | TLX Stock News

Feb 20, 2026, 2:44 AM EST - 24 days ago

Telix Pharmaceuticals Limited (TLX) Q4 2025 Earnings Call Transcript

TLX

2026-02-20T05:04:22.000Z - 24 days ago

Telix Pharmaceuticals Ltd (TLPPF) Full Year 2025 Earnings Call Highlights: Robust Revenue ...

2026-02-20T04:00:11.000Z - 24 days ago

Full Year 2025 Telix Pharmaceuticals Ltd Earnings Call Transcript

Feb 19, 2026, 7:02 PM EST - 24 days ago

FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment

TLX

2026-02-19T23:55:20.000Z - 24 days ago

Telix Pharmaceuticals (TLX) Reports Earnings Miss, Revenue Growth

2026-02-18T06:10:55.000Z - 26 days ago

Telix Submits European Marketing Authorization Application For TLX101-Px

Feb 17, 2026, 4:55 PM EST - 27 days ago

Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging

TLX

Jan 21, 2026, 2:15 PM EST - 7 weeks ago

Telix Pharmaceuticals Reports Strong Full-Year Revenue, But Shares Remain Under Pressure

TLX

Jan 12, 2026, 3:25 PM EST - 2 months ago

Telix Pharmaceuticals Limited (TLX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

TLX

Fri, 09 Jan 2026 15:56:00 -0500 - 2 months ago

Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 – TLX

Fri, 09 Jan 2026 11:57:00 -0500 - 2 months ago

TELIX FINAL CLASS ACTION ALERT: Bragar Eagel & Squire, P.C. Urgently Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights

Fri, 09 Jan 2026 10:10:00 -0500 - 2 months ago

FINAL DEADLINE ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026

Fri, 09 Jan 2026 09:00:00 -0500 - 2 months ago

Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX

Fri, 09 Jan 2026 06:49:00 -0500 - 2 months ago

TLX FINAL DEADLINE ALERT: Hagens Berman Alerts Telix Pharm. (TLX) Investors of Today's Lead Plaintiff Deadline in Securities Class Action

Thu, 08 Jan 2026 19:00:00 -0500 - 2 months ago

TLX Deadline Tomorrow: Rosen Law Firm Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important January 9 Deadline in Securities Class Action First Filed by the Firm – TLX

Thu, 08 Jan 2026 17:46:00 -0500 - 2 months ago

Telix Pharmaceuticals Ltd. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights – TLX

Thu, 08 Jan 2026 13:04:00 -0500 - 2 months ago

Deadline Soon: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud Lawsuit

Thu, 08 Jan 2026 13:00:00 -0500 - 2 months ago

Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman

Thu, 08 Jan 2026 12:00:00 -0500 - 2 months ago

Bronstein, Gewirtz & Grossman LLC Urges Telix Pharmaceuticals Limited Investors to Act: Class Action Filed Alleging Investor Harm

Thu, 08 Jan 2026 11:41:00 -0500 - 2 months ago

DEADLINE TOMORROW: Berger Montague Advises Telix Pharmaceuticals Ltd. (TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

Thu, 08 Jan 2026 09:00:00 -0500 - 2 months ago

Shareholders that lost money on Telix Pharmaceuticals Ltd.(TLX) should contact The Gross Law Firm about pending Class Action - TLX

Jan 8, 2026, 6:00 AM EST - 2 months ago

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

TLX

Wed, 07 Jan 2026 18:02:00 -0500 - 2 months ago

Telix (TLX) 2-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Wed, 07 Jan 2026 15:30:00 -0500 - 2 months ago

Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Jan 7, 2026, 11:39 AM EST - 2 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

TLX

Wed, 07 Jan 2026 09:01:00 -0500 - 2 months ago

FRIDAY DEADLINE: Berger Montague Advises Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

Tue, 06 Jan 2026 16:00:00 -0500 - 2 months ago

Levi & Korsinsky Notifies Shareholders of Telix Pharmaceuticals Ltd. (TLX) of a Class Action Lawsuit and an Upcoming Deadline

Tue, 06 Jan 2026 15:40:00 -0500 - 2 months ago

TLX Deadline: TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Ltd. Securities Fraud Lawsuit Filed by The Rosen Law Firm

Tue, 06 Jan 2026 10:19:00 -0500 - 2 months ago

Portnoy Law Firm Announces Class Action on Behalf of Telix Pharmaceuticals Limited Investors

Tue, 06 Jan 2026 09:00:00 -0500 - 2 months ago

Telix Pharmaceuticals Ltd. Sued for Securities Law Violations - Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your Rights - TLX

Tue, 06 Jan 2026 08:46:00 -0500 - 2 months ago

Telix Pharmaceuticals Ltd. (TLX) Deadline Approaching: Berger Montague Advises Investors of Deadline in Securities Fraud Lawsuit

Mon, 05 Jan 2026 20:14:00 -0500 - 2 months ago

SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Mon, 05 Jan 2026 16:51:00 -0500 - 2 months ago

TELIX URGENT CLASS ACTION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights Before January 9th

Mon, 05 Jan 2026 09:09:00 -0500 - 2 months ago

Telix (TLX) 4-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Mon, 05 Jan 2026 09:00:00 -0500 - 2 months ago

Investors in Telix Pharmaceuticals Ltd. Should Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights - TLX

Mon, 05 Jan 2026 08:36:00 -0500 - 2 months ago

TELIX PHARMACEUTICALS (NASDAQ: TLX) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by January 9, 2026

Sun, 04 Jan 2026 12:00:00 -0500 - 2 months ago

TLX 5-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures

Sun, 04 Jan 2026 08:40:00 -0500 - 2 months ago

SHAREHOLDER ALERT: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026

Dec 23, 2025, 1:12 PM EST - 2 months ago

TLX LAWSUIT DEADLINE: Hagens Berman Urges Telix Investors to Act by Jan. 9 Over Alleged Dual Regulatory Failures: SEC Subpoena & FDA CRL on CMC/Supply Chain

Dec 22, 2025, 10:02 AM EST - 3 months ago

TLX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Dec 21, 2025, 4:38 PM EST - 3 months ago

Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions

Dec 19, 2025, 9:43 AM EST - 3 months ago

TLX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Dec 16, 2025, 3:30 PM EST - 3 months ago

Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately

Dec 15, 2025, 10:40 AM EST - 3 months ago

UPCOMING DEADLINE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Dec 10, 2025, 7:00 AM EST - 3 months ago

Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration

Dec 2, 2025, 5:17 PM EST - 3 months ago

Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability – Hagens Berman

Nov 28, 2025, 5:25 PM EST - 3 months ago

Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman

Nov 28, 2025, 11:44 AM EST - 3 months ago

Bragar Eagel & Squire, P.C. Reminds Investors of Telix Pharmaceuticals and Firefly Aerospace to Contact the Firm About their Rights Before Lead Plaintiff Deadlines

FLY

Nov 24, 2025, 8:45 AM EST - 4 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of January 9, 2026 in Telix Pharmaceuticals Ltd. Lawsuit - TLX

Nov 23, 2025, 6:18 AM EST - 4 months ago

TLX INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals

Nov 19, 2025, 2:00 PM EST - 4 months ago

ZIRCON-X Analysis: TLX250-CDx Impacts Clinical Decision Making for Almost Half of Patients with Indeterminate Renal Masses

Nov 5, 2025, 6:00 AM EST - 4 months ago

Telix to Participate in UBS and Jefferies Global Healthcare Conferences

Oct 23, 2025, 2:08 PM EDT - 5 months ago

Telix Pharmaceuticals Limited Investigated by the Portnoy Law Firm

Oct 22, 2025, 4:00 PM EDT - 5 months ago

Telix Doses First Patient in SOLACE Trial for Metastatic Bone Pain

Oct 15, 2025, 5:13 PM EDT - 5 months ago

TELIX INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Investors to Contact the Firm Regarding Ongoing Investigation on Behalf of Stockholders

Oct 14, 2025, 2:11 PM EDT - 5 months ago

Telix Pharmaceuticals Enters Q4 On Strong Footing With Stabilized Pricing Pressures, Upgraded Annual Sales Guidance

Oct 14, 2025, 2:22 AM EDT - 5 months ago

Telix Reports US$206M Revenue, FY 2025 Guidance Upgraded

Sep 23, 2025, 10:15 AM EDT - 6 months ago

CMS Grants Transitional Pass-Through Status for Gozellix

Sep 19, 2025, 8:30 AM EDT - 6 months ago

Telix Pharmaceuticals Limited (TLX) Hits Another Roadblock After SEC Subpoena, Shares Fall Again -- Hagens Berman

AlertsAndNews Mar. 15 at 9:55 PM

0 · Reply

StockNews_Live Mar. 15 at 9:28 PM

0 · Reply

GreenTeaKor Mar. 10 at 5:48 AM

$TLX hello?

0 · Reply

StockNews_Live Mar. 9 at 11:20 PM

0 · Reply

StockNews_Live Feb. 27 at 12:02 PM

0 · Reply

prismmarketview Feb. 25 at 7:12 PM

0 · Reply

erevnon Feb. 24 at 7:28 PM

Citigroup maintains Telix Pharmaceuticals $TLX at Buy and raises the price target from $22 to https://marketsblock.com/stock-upgrades-and-downgrades/

0 · Reply

DailyAnalysis Feb. 24 at 6:28 PM

0 · Reply

DailyAnalysis Feb. 23 at 3:36 PM

0 · Reply

BillionerOfKing Feb. 23 at 2:30 PM

$TLX Current Stock Price: $6.88

0 · Reply

DailyAnalysis Feb. 22 at 4:55 PM

0 · Reply

DailyAnalysis Feb. 21 at 8:25 PM

$TLX is testing 1W lows after regulatory delays. 1D RSI is oversold, while 4H STOCH and 30M CCI indicate a bottoming process. Strong revenue guidance provides a fundamental floor despite the current technical weakness. @DailyAnalysis

0 · Reply

topstockalerts Feb. 20 at 3:34 PM

$TLX Looks primed for another leg higher. Buyers are still pressing. This trend may not be done yet.

0 · Reply

S144 Feb. 20 at 3:26 PM

$TLX My understanding is: they are going to get FDA approval for Pixclara quickly. "For Pixclara, we have a reasonable idea that it's going to be a rapid review also because it's a single a single issue CRL" "FDA has granted both orphan drug and fast track designation for Pixclara. Our commercial, medical, and supply chain teams are launch ready. Our expanded access programs serve patients and our customers very well, and they anticipate commercial use of Pixclara" "For Zircaix, we've completed 2 Type A meetings with the FDA and believe we have full alignment on key resubmission requirements. We are now focused on completing the agreed deliverables and documentation required for the resubmission. With breakthrough therapy designation, supportive ZIRCON-X data and the inclusion in major international guidelines, this remains a top priority for approval and launch this year. This is a really exciting and highly anticipated product."

0 · Reply

S144 Feb. 20 at 3:20 PM

$TLX Telix Pharmaceuticals Limited (TLX) Q4 2025 Earnings Call Transcript https://seekingalpha.com/article/4872706-telix-pharmaceuticals-limited-tlx-q4-2025-earnings-call-transcript

0 · Reply

S144 Feb. 20 at 3:14 PM

$TLX FY 2025 Full Year Results Presentation https://ir.telixpharma.com/static-files/797e0ea6-3553-4cbb-98f5-12fe182394bf

0 · Reply

S144 Feb. 20 at 3:11 PM

$TLX +16% today ! https://uk.finance.yahoo.com/news/telix-pharmaceuticals-ltd-tlppf-full-050422485.html @alexpitti

0 · Reply

topstockalerts Feb. 20 at 2:57 PM

$TLX One to watch closely today 👀. Momentum is building and price is holding strength. This setup is starting to form.

1 · Reply

mbruland Feb. 20 at 8:46 AM

$TLX Just started a position. Will continue to add as I can.

0 · Reply

Market Cap	2.66B
Revenue (ttm)	803.79M
Net Income (ttm)	-7.13M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	89.71
Profit Margin	-0.89%
Debt to Equity Ratio	0.98

Volume	148,100
Avg Vol	245,830
Day's Range	N/A - N/A
Shares Out	338.78M
Stochastic %K	83%
Beta	0.52
Analysts	Strong Sell
Price Target	$20.90